84-1073-71 BRCA1 (Breast Cancer Antigen, Early Onset Breast Ovarian Cancer Susceptibility Protein 1) 100ul B2709-03
特徴
- Applications:Suitable for use in Western Blot, Immunoprecipitation and Immunohistochemistry.
- Other applications not tested.
- Recommended Dilution:Western Blot: 1:5000-1:10,000 dilution of this lot detected BRCA1 in HeLa nuclear extract
- Immunohistochemistry: This antibody has been reported by an independent laboratory to detect BRCA1 in breast cancer tumor sections.
- Immunoprecipitation: This antibody has been reported by an independent laboratory to immunoprecipitate BRCA1
- Optimal dilutions to be determined by the researcher.
- Included Positive Antigen Control:HeLa nuclear extract.
- Add an equal volume of Laemmli reducing sample buffer to 5-10ul of extract and boil for 5 minutes to reduce the preparation.
- Load 20ug of reduced lysate per lane for minigels.
- Storage and Stability:May be stored at 4°C for short-term only.
- Aliquot to avoid repeated freezing and thawing.
- Store at -20°C.
- Aliquots are stable for 12 months after receipt.
- For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
仕様
- Size:100ul
- Host:rabbit
- Source Antibody:human
- Grade:Serum
- Purity:Serum
- Form:Supplied as a liquid in 0.05% sodium azide, 30% glycerol.
- Specificity:Recognizes human BRCA1, Mr ~220kD. A non-specific protein was also detected at Mr ~50kD.
- Isotype:IgG
- Calc Applications Abbrev:IHC IP WB
- Calc Crossreactivity:Hu
- Immunogen:GST-tagged fusion protein corresponding to aa1301-1863 of human BRCA1
- Shelf Life:1year
- Swiss Prot Number:P38398
- EU Commodity Code:30021010
- この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
- 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
- 【試薬に関するお問合せ】
- アズワン株式会社 試薬・プロセス材料グループ
- TEL:06-6447-8641
- FAX:06-6447-8642
- E-mail:[email protected]